Friday, August 29, 2014
New study reveals PGx knowledge gaps among physicians
›
A recent study in the journal Pharmacogenomics and Personalized Medicine reveals clear pharmacogenomic “knowledge gaps” among physicians. ...
Friday, August 22, 2014
PGx analysis of 482 whole genomes
›
Few studies have analyzed whole genomes for PGx-related variants - instead, many utilize genotyping platforms made up of known variants. A r...
Tuesday, August 19, 2014
New PharmGKB pathway: Paroxetine
›
The paroxetine PK pathway is the newest addition to PharmGKB's pathway summaries . Paroxetine is a selective serotonin reuptake inhi...
Wednesday, August 6, 2014
New PharmGKB VIP Summary: HLA-B
›
Human leukocyte antigen B (HLA-B) is a cell-surface molecule responsible for the presentation of endogenous peptides to cytotoxic CD8+ T ce...
Monday, August 4, 2014
European approval of additional CFTR variants listed for ivacaftor use
›
The drug Ivacaftor (Kalydeco) was originally indicated for use in cystic fibrosis (CF) patients with one or two copies of the G551D variant ...
Tuesday, July 29, 2014
Praise for PharmGKB
›
PharmGKB is “the Holy Grail” for DNA STAT , a company that provides pharmacogenomics testing for patients. DNA STAT g...
Friday, July 25, 2014
Ifosfamide PK and PD pathways published in PG&G
›
Ifosfamide is a produg used in combination chemotherapy for the treatment of solid tumors. Around 20% of patients experience toxicity. Pathw...
‹
›
Home
View web version
